64 related articles for article (PubMed ID: 23207563)
1. Clenbuterol favorably remodels neonatal cardiac cells via activation of p38 MAPK signalling pathway.
Spanou D; Perimenis P; Mantzouratou P; Gomatos C; Cokkinos D; Mourouzis I; Pantos C
J Cardiovasc Surg (Torino); 2012 Dec; 53(6):789-95. PubMed ID: 23207563
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: potential therapeutic implications in reversing cardiac remodeling?
Pantos C; Xinaris C; Mourouzis I; Malliopoulou V; Kardami E; Cokkinos DV
Mol Cell Biochem; 2007 Mar; 297(1-2):65-72. PubMed ID: 17024559
[TBL] [Abstract][Full Text] [Related]
3. Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure.
Soppa GK; Lee J; Stagg MA; Felkin LE; Barton PJ; Siedlecka U; Youssef S; Yacoub MH; Terracciano CM
Cardiovasc Res; 2008 Mar; 77(4):695-706. PubMed ID: 18178572
[TBL] [Abstract][Full Text] [Related]
4. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.
Cheng TH; Shih NL; Chen CH; Lin H; Liu JC; Chao HH; Liou JY; Chen YL; Tsai HW; Chen YS; Cheng CF; Chen JJ
J Biomed Sci; 2005; 12(1):123-33. PubMed ID: 15864745
[TBL] [Abstract][Full Text] [Related]
5. Endogenous BNP attenuates cardiomyocyte hypertrophy induced by Ang II via p38 MAPK/Smad signaling.
Chen Y; Yao F; Chen S; Huang H; Wu L; He J; Dong Y
Pharmazie; 2014 Nov; 69(11):833-7. PubMed ID: 25985580
[TBL] [Abstract][Full Text] [Related]
6. Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles.
Bricout VA; Serrurier BD; Bigard AX
Acta Physiol Scand; 2004 Mar; 180(3):271-80. PubMed ID: 14962009
[TBL] [Abstract][Full Text] [Related]
7. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1.
Fan GC; Yuan Q; Song G; Wang Y; Chen G; Qian J; Zhou X; Lee YJ; Ashraf M; Kranias EG
Circ Res; 2006 Nov; 99(11):1233-42. PubMed ID: 17068291
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor gene ING3 induces cardiomyocyte hypertrophy via inhibition of AMPK and activation of p38 MAPK signaling.
Wang J; Liu Z; Feng X; Gao S; Xu S; Liu P
Arch Biochem Biophys; 2014 Nov; 562():22-30. PubMed ID: 25151306
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle.
Soppa GK; Smolenski RT; Latif N; Yuen AH; Malik A; Karbowska J; Kochan Z; Terracciano CM; Yacoub MH
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1468-76. PubMed ID: 15528231
[TBL] [Abstract][Full Text] [Related]
10. p38 mitogen-activated protein kinase (MAPK) is activated by noradrenaline and serves a cardioprotective role, whereas adrenaline induces p38 MAPK dephosphorylation.
Tsang MY; Rabkin SW
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):e12-9. PubMed ID: 19413597
[TBL] [Abstract][Full Text] [Related]
11. AMPK activation enhances PPARĪ± activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
[TBL] [Abstract][Full Text] [Related]
12. Effect of beta2-adrenergic agonist clenbuterol on ischemia/reperfusion injury in isolated rat hearts and cardiomyocyte apoptosis induced by hydrogen peroxide.
Liu P; Xiang JZ; Zhao L; Yang L; Hu BR; Fu Q
Acta Pharmacol Sin; 2008 Jun; 29(6):661-9. PubMed ID: 18501112
[TBL] [Abstract][Full Text] [Related]
13. Chronic oral administration of beta-adrenoceptor agonist clenbuterol affects myosin heavy chain (MHC) expression in adult mouse heart.
Patiyal SN; Sharma S
Physiol Res; 2007; 56(3):275-283. PubMed ID: 16792469
[TBL] [Abstract][Full Text] [Related]
14. Nestin Expressed by Pre-Existing Cardiomyocytes Recapitulated in Part an Embryonic Phenotype; Suppressive Role of p38 MAPK.
Meus MA; Hertig V; Villeneuve L; Jasmin JF; Calderone A
J Cell Physiol; 2017 Jul; 232(7):1717-1727. PubMed ID: 27439108
[TBL] [Abstract][Full Text] [Related]
15. Chronic clenbuterol administration alters myosin heavy chain composition in standardbred mares.
Beekley MD; Ideus JM; Brechue WF; Kearns CF; McKeever KH
Vet J; 2003 May; 165(3):234-9. PubMed ID: 12672369
[TBL] [Abstract][Full Text] [Related]
16. Regulation of glucose transporter expression in cardiac myocytes: p38 MAPK is a strong inducer of GLUT4.
Montessuit C; Rosenblatt-Velin N; Papageorgiou I; Campos L; Pellieux C; Palma T; Lerch R
Cardiovasc Res; 2004 Oct; 64(1):94-104. PubMed ID: 15364617
[TBL] [Abstract][Full Text] [Related]
17. Both JNK and P38 MAPK pathways participate in the protection by dexmedetomidine against isoflurane-induced neuroapoptosis in the hippocampus of neonatal rats.
Liao Z; Cao D; Han X; Liu C; Peng J; Zuo Z; Wang F; Li Y
Brain Res Bull; 2014 Aug; 107():69-78. PubMed ID: 25026397
[TBL] [Abstract][Full Text] [Related]
18. Effects of triiodo-thyronine on angiotensin-induced cardiomyocyte hypertrophy: reversal of increased beta-myosin heavy chain gene expression.
Wang B; Ouyang J; Xia Z
Can J Physiol Pharmacol; 2006; 84(8-9):935-41. PubMed ID: 17111039
[TBL] [Abstract][Full Text] [Related]
19. Activation of extracellular signal-regulated kinase during silibinin-protected, isoproterenol-induced apoptosis in rat cardiac myocytes is tyrosine kinase pathway-mediated and protein kinase C-dependent.
Zhou B; Wu LJ; Tashiro S; Onodera S; Uchiumi F; Ikejima T
Acta Pharmacol Sin; 2007 Jun; 28(6):803-10. PubMed ID: 17506939
[TBL] [Abstract][Full Text] [Related]
20. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
